Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man - PubMed

• PMID: 3012605

Review

Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man

S Agurell et al. Pharmacol Rev. 1986 Mar.

Similar articles

• Plasma cannabinoids measured by radioimmunoassay in rabbits after intravenous injection of tetrahydrocannibinol, 11-hydroxy-tetrahydrocannabinol, cannabinol and cannabidiol.

  Teale JD, Clough JM, Piall EM, King LJ, Marks V. Teale JD, et al. Res Commun Chem Pathol Pharmacol. 1975 Jun;11(2):339-42. Res Commun Chem Pathol Pharmacol. 1975. PMID: 1153879

• Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.

  Lemberger L, Martz R, Rodda B, Forney R, Rowe H. Lemberger L, et al. J Clin Invest. 1973 Oct;52(10):2411-7. doi: 10.1172/JCI107431. J Clin Invest. 1973. PMID: 4729039 Free PMC article.

• Metabolism and disposition of delta-9-tetrahydrocannabinol in man.

  Lemberger L, Axelrod J, Kopin IJ. Lemberger L, et al. Pharmacol Rev. 1971 Dec;23(4):371-80. Pharmacol Rev. 1971. PMID: 4943951 Review. No abstract available.

• Biological disposition of tetrahydrocannabinols.

  Truitt EB Jr. Truitt EB Jr. Pharmacol Rev. 1971 Dec;23(4):273-8. Pharmacol Rev. 1971. PMID: 4399986 No abstract available.

• Human effects.

  Jones R. Jones R. NIDA Res Monogr. 1977 Jul;(14):128-78. NIDA Res Monogr. 1977. PMID: 411040 Review. No abstract available.

Cited by

• Weighing the Evidence: A Systematic Review on Long-Term Neurocognitive Effects of Cannabis Use in Abstinent Adolescents and Adults.

  Ganzer F, Bröning S, Kraft S, Sack PM, Thomasius R. Ganzer F, et al. Neuropsychol Rev. 2016 Jun;26(2):186-222. doi: 10.1007/s11065-016-9316-2. Epub 2016 Apr 28. Neuropsychol Rev. 2016. PMID: 27125202 Review.

• Nasal accumulation and metabolism of Δ⁹-tetrahydrocannabinol following aerosol ('vaping') administration in an adolescent rat model.

  Torrens A, Ruiz CM, Martinez MX, Tagne AM, Roy P, Grimes D, Ahmed F, Lallai V, Inshishian V, Bautista M, Chen YC, Huestis MA, Das A, Fowler CD, Mahler SV, Piomelli D. Torrens A, et al. Pharmacol Res. 2023 Jan;187:106600. doi: 10.1016/j.phrs.2022.106600. Epub 2022 Dec 5. Pharmacol Res. 2023. PMID: 36481259 Free PMC article.

• Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.

  Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V. Bisogno T, et al. Br J Pharmacol. 2001 Oct;134(4):845-52. doi: 10.1038/sj.bjp.0704327. Br J Pharmacol. 2001. PMID: 11606325 Free PMC article.

• Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.

  Tanda G, Goldberg SR. Tanda G, et al. Psychopharmacology (Berl). 2003 Sep;169(2):115-34. doi: 10.1007/s00213-003-1485-z. Epub 2003 Jun 24. Psychopharmacology (Berl). 2003. PMID: 12827346 Review.

• Dosing medical marijuana: rational guidelines on trial in Washington State.

  Aggarwal SK, Kyashna-Tocha M, Carter GT. Aggarwal SK, et al. MedGenMed. 2007 Sep 11;9(3):52. MedGenMed. 2007. PMID: 18092058 Free PMC article. No abstract available.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database